AI assistant
CVRx, Inc. — Director's Dealing 2024
Feb 2, 2024
33690_dirs_2024-02-02_14564b48-74a8-41a4-a6f3-4021aa65ef18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2023-09-15
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 237 | Disposed | 2023-12-14 | Common Stock (237) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 158 | Disposed | 2024-11-18 | Common Stock (158) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 189 | Disposed | 2025-08-06 | Common Stock (189) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 165 | Disposed | 2025-08-06 | Common Stock (165) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 118 | Disposed | 2025-08-06 | Common Stock (118) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 71 | Disposed | 2025-08-06 | Common Stock (71) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 23 | Disposed | 2025-08-06 | Common Stock (23) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 85 | Disposed | 2025-11-09 | Common Stock (85) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 758 | Disposed | 2027-02-01 | Common Stock (758) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 489 | Disposed | 2027-02-01 | Common Stock (489) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 758 | Disposed | 2028-02-15 | Common Stock (758) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $0.237 | J | 300 | Disposed | 2028-02-15 | Common Stock (300) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $1.186 | J | 758 | Disposed | 2028-11-28 | Common Stock (758) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $1.186 | J | 142 | Disposed | 2028-11-28 | Common Stock (142) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $3.955 | J | 758 | Disposed | 2029-12-05 | Common Stock (758) | Direct |
| 2023-09-15 | Stock Option (Right to Buy) | $5.141 | J | 1264 | Disposed | 2031-01-04 | Common Stock (1264) | Direct |
Footnotes
F1: This Form 4 Amendment is being filed solely to report the Stock Options that were inadvertently omitted from the Form 4 filed by the Reporting Person on September 18, 2023. The beneficial ownership and pecuniary interest of Johnson & Johnson ("J&J") in the securities reported herein has not changed. On September 15, 2023, Johnson & Johnson Innovation - JJDC, Inc., a New Jersey corporation and wholly-owned subsidiary of J&J ("Old JJDC") completed an internal reorganization, whereby, through a series of transactions, Old JJDC merged with and into a newly-formed wholly-owned subsidiary of J&J organized under Delaware law,
F2: (Continued from footnote 1) ultimately resulting in all assets and securities owned by Old JJDC now being held by a Delaware corporation also named "Johnson & Johnson Innovation - JJDC, Inc." ("New JJDC"). By operation of law, the securities reported herein are now held directly by New JJDC. A separate Form 3 Amendment will be filed to disclose New JJDC's beneficial ownership of the securities reported herein.
F3: Fully vested.
F4: Vests as to 1/48th of the shares each month commencing January 6, 2020.
F5: Vests as to 1/48th of the shares each month commencing January 11, 2021.